As of 14 Oct 2026, Ray Therapeutics has raised $125M across 1 verified round on record; latest: $125 million Series B led by Janus Henderson Investors, announced 21 Apr 2026.
Optogenetic therapies designed to restore functional vision for people with degenerative retinal diseases.
raytherapeutics.comLinkedInBerkeley, California
1 source
The financing includes both new investors and existing investors providing follow-on support; all are included in the round's investor list.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2026-04-21 | Janus Henderson Investors | No recent discussion |
1 source [ VERIFIED ] read against 1 source The financing includes both new investors and existing investors providing follow-on support; all are included in the round's investor list. | ||||